Biogen (BIIB) Tops Q4 EPS by 25c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $250.69 -1.24%
Revenue Growth %: +4.3%
Financial Fact:
Total cost and expenses: 1.53B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +4.3%
Financial Fact:
Total cost and expenses: 1.53B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q4 EPS of $6.99, $0.25 better than the analyst estimate of $6.74. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.39 billion.
GUIDANCE:
Biogen sees FY2019 EPS of $28.00-$29.00, versus the consensus of $28.02. Biogen sees FY2019 revenue of $13.6-13.8 billion, versus the consensus of $13.63 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Western Digital (WDC) Tops Q1 EPS by 56c, Offers Guidance
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
